The membership of the panel at Musk’s company, Neuralink, raises questions about potential violations of conflict-of-interest regulations aimed at protecting research integrity, a dozen animal-research and bioethics experts told Reuters. Neuralink is conducting animal experiments as it seeks regulatory approval for human trials of a brain chip intended to help paralyzed people type with their minds, among other ambitious goals.

Elanco Animal Health said on Tuesday the U.S. Department of Agriculture (USDA) has provided a conditional license for its antibody to treat canine parvovirus, making it the first approved therapy.